A Certificate of Analysis is the single document that distinguishes "I think this is semaglutide" from "I have evidence of what is in this vial." Anyone injecting compounds should be able to read one. This guide walks through every section, explains the analytics, and flags the red signals for fake or recycled documents.
A Certificate of Analysis is a batch-specific lab report that documents the identity, purity, and safety metrics of a synthesized compound. It is generated at the end of manufacturing, ideally by an independent analytical laboratory, and should accompany every vial of research or pharmaceutical-grade peptide.
Without a COA, you have:
This is not theoretical. Independent testing of research peptides has repeatedly found mislabeled contents, wildly varying potency, and products that contain the wrong peptide entirely. A COA — even a vendor-issued one — shifts the situation from "trust the label" to "trust the documented lab result."
A complete, well-formatted COA contains roughly nine sections. Not every COA has all nine, but the absence of multiple sections is itself a signal.
| Section | What it tells you |
|---|---|
| 1. Product identity | Peptide name, molecular formula, theoretical molecular weight, sequence (single-letter amino acid code) |
| 2. Batch / lot number | Unique identifier tying the COA to a specific manufacturing run — should match vial label |
| 3. Manufacturing date | When synthesis was completed; some COAs include retest or expiry date |
| 4. Physical appearance | Typically "white to off-white lyophilized powder" |
| 5. HPLC purity | Primary purity metric, with chromatogram attached — see section below |
| 6. Mass spectrometry | Identity confirmation via measured molecular weight — see section below |
| 7. Water content | Karl Fischer titration, typically < 5–8%. Higher values mean less peptide per mg. |
| 8. Endotoxin / LAL | Bacterial pyrogen level. Required for injectables; often missing on research-grade COAs |
| 9. Analyst signature + lab details | Who tested it, at what lab, on what date — key for third-party verification |
High-Performance Liquid Chromatography (HPLC) is the standard technique for peptide purity. The principle is simple: a liquid sample is pushed through a column packed with a stationary material. Different compounds interact with the column with different affinity, so they emerge (or "elute") at different times. A detector on the output records each as a peak on a chromatogram.
Purity is calculated as: (main peak area ÷ total peak area) × 100. A peptide labeled "> 98% pure by HPLC" means 98% of the UV-detectable material in that sample is the target peptide. The remaining 2% is other stuff — which is why endotoxin and heavy metals testing also matters for injectables.
Mass spectrometry (MS) confirms identity where HPLC measures purity. The sample is ionized and accelerated through a field; the instrument measures each molecule's mass-to-charge ratio. The output is a spectrum with a dominant peak at the molecular weight of the target compound.
For semaglutide, the theoretical monoisotopic mass is ~4113.6 Da. A COA showing a measured mass matching this value (within instrument tolerance, typically ±0.5 Da or better for modern MS) confirms the vial contains semaglutide. A measured mass far from the theoretical value is a hard fail — regardless of what the HPLC says.
Common MS techniques used on COAs:
Bacterial endotoxin is a structural component of Gram-negative bacteria cell walls. Even tiny amounts in an injectable cause fever, chills, and systemic inflammation. The Limulus Amebocyte Lysate (LAL) assay detects endotoxin at sub-nanogram levels.
Results are reported in Endotoxin Units (EU) per mg of peptide. For injectable use, < 10 EU/mg is a typical ceiling; pharmaceutical-grade compounds are often < 1 EU/mg. Missing endotoxin data on a COA for an injectable compound is a meaningful gap.
Lyophilized peptides always retain a small amount of water. Karl Fischer titration measures it precisely. Typical values:
Residual lead, arsenic, cadmium, and mercury from synthesis reagents should be below pharmacopoeial limits (typically < 10 ppm for each, often much lower). Heavy metals data is more common on pharmaceutical-grade COAs than research-grade ones.
| Metric | Research grade | Pharma grade |
|---|---|---|
| HPLC purity | > 98% | > 99.5% |
| Mass spec identity | Within ±1 Da | Within ±0.5 Da |
| Water content | < 8% | < 5% |
| Endotoxin | Often untested or < 10 EU/mg | < 1 EU/mg |
| Heavy metals | Often untested | Tested, < pharmacopoeial limits |
| Third-party lab | Variable | Standard |
Signs a COA is fake, recycled, or not worth the PDF it is printed on:
A batch-specific lab report documenting identity, purity, and quality of a synthesized peptide. The primary document verifying what is in the vial.
Research-grade: > 98% by HPLC. Pharma-grade: > 99.5%. Below 95% should be approached with caution.
Match batch number to vial label, verify the testing lab exists, check that analytical traces are attached (not just summary numbers), and prefer third-party over in-house testing.
Separates components of the vial by retention time; each appears as a peak. Main peak = target peptide; purity is its area as a percentage of total peak area.
Identity. The measured molecular weight should match the theoretical value for the claimed peptide. HPLC measures purity; MS confirms identity.
For injectable peptides, yes — both are meaningful safety metrics. Pharmaceutical-grade COAs include them; research-grade often omit them.
Peptide Protocol stores batch numbers and COA references per vial, so when anything unusual happens you can trace it back to the source rather than scrolling chat history.
Get the iPhone app →Educational use only. This guide is for research and informational purposes. It is not medical, legal, or regulatory advice. Always follow applicable laws regarding peptide acquisition and use in your jurisdiction.